Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Crispr Therapeutics AG (CRSP) – Crispr Therapeutics AG Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

CRISPR Therapeutics (CRSP) trades at $56.38, up 5.32% in 24 hours, with technical indicators showing bullish momentum as the price sits above key support levels. The company continues to operate at a loss with negative profit margins, but maintains strong analyst support with a consensus price target of $82.67. Recent news highlights upcoming investor conferences and pipeline catalysts, while Casgevy commercialization progresses.
The outlook remains speculative with significant execution risk given ongoing losses and cash burn, but potential for substantial upside exists if pipeline programs deliver positive data. Key risks include slow Casgevy adoption, clinical trial setbacks, and continued negative cash flow from operations requiring external financing.
Read full analysis

Key Stats

  • Market Cap
    $5.42B
  • Sector
    Health
  • 3M Drawdown
    -27.04%
  • Enterprise Value
    $3.76B
  • Dividend Yield
    -
  • Trading Activity
    2% Buy | 98% Sell
  • Typical Hold Time
    70 days
$56.18
52W Low: $36.29
30 May 2025
52W High: $76.78
08 Oct 2025

Crispr Therapeutics AG (CRSP) is currently valued at a market capitalization of $5.42B, with an enterprise value of $3.76B. Over the past 52 weeks, Crispr Therapeutics AG has traded between a low of $36.29 and a high of $76.78, highlighting its annual price range. Over the past three months, Crispr Therapeutics AG has recorded a drawdown of -27.04%, reflecting recent price volatility. On average, investors hold Crispr Therapeutics AG for approximately 70 days, indicating typical investor behavior on the platform.

About Crispr Therapeutics AG

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $5.42B
  • Sector
    Health
  • 3M Drawdown
    -27.04%
  • Enterprise Value
    $3.76B
  • Dividend Yield
    -
  • Trading Activity
    2% Buy | 98% Sell
  • Typical Hold Time
    70 days
$56.18
52W Low: $36.29
30 May 2025
52W High: $76.78
08 Oct 2025

Crispr Therapeutics AG (CRSP) is currently valued at a market capitalization of $5.42B, with an enterprise value of $3.76B. Over the past 52 weeks, Crispr Therapeutics AG has traded between a low of $36.29 and a high of $76.78, highlighting its annual price range. Over the past three months, Crispr Therapeutics AG has recorded a drawdown of -27.04%, reflecting recent price volatility. On average, investors hold Crispr Therapeutics AG for approximately 70 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!